Command Palette

Search for a command to run...

Clinical Trials · NCT04741074

Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy

TerminatedPhase 3Semaglutide (Prohibited)
Phase
Phase 3
Recruitment status
Terminated
Sponsor
Geisinger Clinic
Enrollment
15
Start date
Jul 2021
Locations
2 sites, United States
Primary endpoint
Kidney Transplant Eligibility
View Semaglutide compound reference